MENU
CATX
AS OF
Jan 14, 04:59 PM (EDT)
Price
$2.62
Change
+$0.11 (+4.38%)
Capitalization
186.59M
71 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
CATX
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION

Perspective Therapeutics (CATX) Ownership - Who owns Perspective Therapeutics?

Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com

Details

Group
Domestic Stock Funds
Category
Health Services
Capitalization
186.59M
P/E Ratio
N/A
Total Cash
174.14M
Projected Growth
N/A
Total Debt
3.31M
Revenue
N/A
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash/Share
2.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

CATX
Capitalization
187M
P/E Ratio
N/A
Risk (Beta)
2.73
Dividend Yield
N/A
Total Cash
174M
Total Cash/Share
2.34
Total Debt
3.31M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
242M
P/B Ratio
0.77
Cash Flow
N/A
Earnings
-1.5
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
74K
Current Ratio
8.66
Current Revenue Per Employee
20978.02
Dividends Per Share - Security
N/A
EBITDA
-105.22M
Float
N/A
Float - Current
N/A
Gross Income Margin
38.66
Revenue To Assets
-30.85
Shares Held By Institutions
220M
Shares Outstanding - Current
74.3M
Total Liabilities
52.6M
Total Volume MTD
N/A
Value
-1
Gain YTD
-8.727
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
CATX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. CATX showed earnings on November 10, 2025. You can read more about the earnings report here.
View AI-Driven Trading for CATX
A.I. Advisor
published General Information

General Information

a producer of therapeutic radioactive isotopes

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Biotechnology
Address
2401 Elliott Avenue
Phone
+1 206 676-0900
Employees
119
Web
https://www.perspectivetherapeutics.com